Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2017 1
2018 1
2019 1
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

5 results
Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Comparison of Pueraria mirifica gel and conjugated equine estrogen cream effects on vaginal health in postmenopausal women.
Suwanvesh N, Manonai J, Sophonsritsuk A, Cherdshewasart W. Suwanvesh N, et al. Menopause. 2017 Feb;24(2):210-215. doi: 10.1097/GME.0000000000000742. Menopause. 2017. PMID: 27749740 Clinical Trial.
OBJECTIVES: To compare the effects of a 12-week treatment with Pueraria mirifica (PM) gel or a conjugated estrogen cream on vaginal maturation index, vaginal symptom score, vaginal health assessment score, and vaginal flora …
OBJECTIVES: To compare the effects of a 12-week treatment with Pueraria mirifica (PM) gel or a conjugated estrogen crea …
An overview of the phytoestrogen effect on vaginal health and dyspareunia in peri- and post-menopausal women.
Dizavandi FR, Ghazanfarpour M, Roozbeh N, Kargarfard L, Khadivzadeh T, Dashti S. Dizavandi FR, et al. Post Reprod Health. 2019 Mar;25(1):11-20. doi: 10.1177/2053369118823365. Epub 2019 Feb 20. Post Reprod Health. 2019. PMID: 30786797 Review.
OBJECTIVE: The aim of this overview was to evaluate the effectiveness of phytoestrogens on vaginal health and dyspareunia in peri- and post-menopausal women. ...However, the conjugated estrogen cream was more effective compared to Pueraria mi
OBJECTIVE: The aim of this overview was to evaluate the effectiveness of phytoestrogens on vaginal health and dyspareun …
Effect of Pueraria mirifica on vaginal health.
Manonai J, Chittacharoen A, Theppisai U, Theppisai H. Manonai J, et al. Menopause. 2007 Sep-Oct;14(5):919-24. doi: 10.1097/gme.0b013e3180399486. Menopause. 2007. PMID: 17415017 Clinical Trial.
OBJECTIVE: To evaluate the effect of Pueraria mirifica on vaginal symptoms, vaginal health index, vaginal pH, and vaginal cytology in healthy postmenopausal women. ...There was no significant difference of adverse effects
OBJECTIVE: To evaluate the effect of Pueraria mirifica on vaginal symptoms, vaginal health index, …
Efficacy and safety of Pueraria candollei var. mirifica (Airy Shaw & Suvat.) Niyomdham for menopausal women: A systematic review of clinical trials and the way forward.
Kongkaew C, Scholfield NC, Dhippayom T, Dilokthornsakul P, Saokaew S, Chaiyakunapruk N. Kongkaew C, et al. J Ethnopharmacol. 2018 Apr 24;216:162-174. doi: 10.1016/j.jep.2018.01.028. Epub 2018 Feb 6. J Ethnopharmacol. 2018. PMID: 29409850 Review.
ETHNOPHARMACOLOGICAL RELEVANCE: Pueraria candollei var. mirifica (Airy Shaw & Suvat.) Niyomdham (commonly termed P. mirifica, PM) growing in upland Thailand has a long history as a postmenopausal rejuvenant therapy for indigenants. ...Other PM studies usi …
ETHNOPHARMACOLOGICAL RELEVANCE: Pueraria candollei var. mirifica (Airy Shaw & Suvat.) Niyomdham (commonly termed P. mir
Comparison of the effects of Pueraria mirifica gel and of placebo gel on the vaginal microenvironment of postmenopausal women with Genitourinary Syndrome of Menopause (GSM).
Sritonchai C, Manonai J, Sophonsritsuk A, Cherdshewasart W. Sritonchai C, et al. Maturitas. 2020 Oct;140:49-54. doi: 10.1016/j.maturitas.2020.06.005. Epub 2020 Jun 13. Maturitas. 2020. PMID: 32972635 Clinical Trial.
OBJECTIVE: To compare the effects of a 12-week course of 5%Pueraria mirifica gel and placebo gel on the prevalence of bacterial vaginosis, vaginal fungi, vaginal pH, vaginal health index (VHI), and genitourinary symptoms in postmen …
OBJECTIVE: To compare the effects of a 12-week course of 5%Pueraria mirifica gel and placebo gel on the prevalence of b …
Feedback